Fundraising FoxPrecision Virologics
St. Louis, US · Founded 2016 · Delaware corporation
Find your way into Precision Virologics
Sign up to see every warm intro you have to Precision Virologics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Precision Virologics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DE
Daniel E. KatzmanCEO2016–2020Daniel Katzman is executive officer and director at Precision Virologics. He previously led Unleash Immuno Oncolytics through its acquisition by TransCode Therapeutics, and is co-founder and chairman of Asclepii, a regenerative medicine company focused on wound care technologies.
DT
David T CurielNamed on SEC filing
Board
YK
Yasunari KashiharaBoard director
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2017
▶$500KraisedApr 2017 · 1 investors · Other Health CareRule 506(b)
▶$500KraisedApr 2017 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Yasunari KashiharaDirector
- Daniel E. KatzmanExecutive Officer, Director
- David T CurielExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $500K
- Minimum investment
- $50K
- Proceeds to insiders
- $72K
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Precision Virologics raised?
- Precision Virologics has disclosed $500K raised across 1 round.
- Where is Precision Virologics headquartered?
- Precision Virologics is headquartered in St. Louis, US.